Ubiquitination Is Required for the Retro-translocation of a Short-lived Luminal Endoplasmic Reticulum Glycoprotein to the Cytosol for Degradation by the Proteasome*
Abstract
In the endoplasmic reticulum (ER), an efficient “quality control system” operates to ensure that mutated and incorrectly folded proteins are selectively degraded. We are studying ER-associated degradation using a truncated variant of the rough ER-specific type I transmembrane glycoprotein, ribophorin I. The truncated polypeptide (RI332) consists of only the 332 amino-terminal amino acids of the protein corresponding to most of its luminal domain and, in contrast to the long-lived endogenous ribophorin I, is rapidly degraded.
Here we show that the ubiquitin-proteasome pathway is involved in the destruction of the truncated ribophorin I. Thus, when RI332that itself appears to be a substrate for ubiquitination was expressed in a mutant hamster cell line harboring a temperature-sensitive mutation in the ubiquitin-activating enzyme E1 affecting ubiquitin-dependent proteolysis, the protein is dramatically stabilized at the restrictive temperature. Moreover, inhibitors of proteasome function effectively block the degradation of RI332. Cell fractionation experiments indicate that RI332 accumulates in the cytosol when degradation is prevented by proteasome inhibitors but remains associated with the lumen of the ER under ubiquitination-deficient conditions, suggesting that the release of the protein into the cytosol is ubiquitination-dependent. Accordingly, when ubiquitination is impaired, a considerable amount of RI332 binds to the ER chaperone calnexin and to the Sec61 complex that could effect retro-translocation of the polypeptide to the cytosol. Before proteolysis of RI332, its N-linked oligosaccharide is cleaved in two distinct steps, the first of which might occur when the protein is still associated with the ER, as the trimmed glycoprotein intermediate efficiently interacts with calnexin and Sec61.
From our data we conclude that the steps that lead a newly synthesized luminal ER glycoprotein to degradation by the proteasome are tightly coupled and that especially ubiquitination plays a crucial role in the retro-translocation of the substrate protein for proteolysis to the cytosol.
Footnotes
-
↵* This work was supported by funds from the Buss Foundation of the University of Vienna School of Medicine and from the Herzfelder Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵‡ To whom correspondence should be addressed: Dept. of Molecular Genetics, University and Biocenter Vienna, Dr. Bohr-Gasse 9/2, A-1030 Vienna, Austria. Tel: 43-1-79515-2112; Fax: 43-1-79515-2900; E-mail:ivessa{at}mol.univie.ac.at.
-
↵1 The abbreviations used are: ER, endoplasmic reticulum; ALLN,N-acetyl-l-leucyl-l-leucyl-l-norleucinal; α1-AT, α1-antitrypsin; BFA, brefeldin A; CFTR, cystic fibrosis transmembrane conductance regulator; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; CHO, Chinese hamster ovary; CPY*, a mutant form of carboxypeptidase Y; endo H, endoglycosidase H; leupeptin, acetyl-l-leucyl-l-leucyl-l-argininal; NEM, N-ethylmaleimide; PAGE, polyacrylamide gel electrophoresis; PDI, protein disulfide isomerase; PMSF, phenylmethylsulfonyl fluoride; RI332, a truncated form of ribophorin I containing its 332 NH2-terminal amino acids; MHC, major histocompatibility complex; TCR, T cell antigen receptor; TLCK,N α-p-tosyl-l-lysine chloromethyl ketone; TPCK,N-tosyl-l-phenylalanine chloromethyl ketone; Tricine, N-tris(hydroxymethyl)methylglycine; ZLLL, carbobenzoxy-l-leucyl-l-leucyl-l-leucinal; ZLLNva, carbobenzoxy-l-leucyl-l-leucyl-l-norvalinal.
-
- Received October 7, 1997.
- Revision received January 30, 1998.
- The American Society for Biochemistry and Molecular Biology, Inc.











